» Articles » PMID: 34217425

Acute Respiratory Distress Syndrome

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2021 Jul 4
PMID 34217425
Citations 377
Authors
Affiliations
Soon will be listed here.
Abstract

Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential diagnosis, and evidence-based clinical management of both mechanical ventilation and supportive care, and discuss areas of controversy and ongoing research. Although the Seminar focuses on ARDS due to any cause, we also consider commonalities and distinctions of COVID-19-associated ARDS compared with ARDS from other causes.

Citing Articles

Role of innate immunity in SARS-CoV-2 infection.

Wang Z, Cheng F, Xu Y, Li X, Meng S Biosaf Health. 2025; 5(5):280-288.

PMID: 40078906 PMC: 11894970. DOI: 10.1016/j.bsheal.2023.08.005.


Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.

Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P Signal Transduct Target Ther. 2025; 10(1):75.

PMID: 40050633 PMC: 11885678. DOI: 10.1038/s41392-025-02127-9.


Neutrophil-derived heparin-binding protein increases endothelial permeability in acute lung injury by promoting TRIM21 and the ubiquitination of P65.

Zhang J, Cao Y, Shu W, Dong S, Sun Y, Ma X Cell Biol Toxicol. 2025; 41(1):55.

PMID: 40045003 PMC: 11882632. DOI: 10.1007/s10565-025-10005-x.


Macrophage pyroptosis and its crucial role in ALI/ARDS.

Cai Y, Shang L, Zhou F, Zhang M, Li J, Wang S Front Immunol. 2025; 16:1530849.

PMID: 40028334 PMC: 11867949. DOI: 10.3389/fimmu.2025.1530849.


Gravitational distribution of regional intrapulmonary shunt assessed by EIT in ARDS.

Xu M, Chi Y, Yuan S, Gao Y, Sun X, Long Y Respir Res. 2025; 26(1):66.

PMID: 39987063 PMC: 11847383. DOI: 10.1186/s12931-025-03141-9.


References
1.
Matthay M, McAuley D, Ware L . Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med. 2017; 5(6):524-534. DOI: 10.1016/S2213-2600(17)30188-1. View

2.
Staub N . Pulmonary edema: physiologic approaches to management. Chest. 1978; 74(5):559-64. DOI: 10.1378/chest.74.5.559. View

3.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

4.
. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA. 2000; 283(15):1995-2002. DOI: 10.1001/jama.283.15.1995. View

5.
Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D . COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300. PMC: 7233352. DOI: 10.1164/rccm.202003-0817LE. View